MICRORAPTOR REGENESORB Suture Anchor

K180361 · Smith and Nephew, Inc. · MAI · May 30, 2018 · Orthopedic

Device Facts

• Record ID: K180361
• Device Name: MICRORAPTOR REGENESORB Suture Anchor
• Applicant: Smith and Nephew, Inc.
• Product Code: MAI · Orthopedic
• Decision Date: May 30, 2018
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 888.3030
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Smith & Nephew MICRORAPTOR Suture Anchor is intended for the reattachment of soft tissue to bone for the following indications: Hip Acetabular labrum repair/reconstruction Shoulder - Capsular stabilization - Bankart repair - Anterior shoulder instability - SLAP lesion repairs - Capsular shift or capsulolabral reconstructions - Biceps tenodesis

Device Story

Suture anchor system for soft tissue-to-bone reattachment. Consists of absorbable REGENESORB anchor, ULTRABRAID suture, and associated inserter/drill/insertion instruments. Used by surgeons in orthopedic procedures (hip/shoulder). Implanted into bone to secure soft tissue. Provides mechanical fixation during healing. Provided sterile for single use.

Clinical Evidence

Bench testing only. Bacterial endotoxin testing met ANSI/AAMI ST72:2011 limits. Performance specifications for insertion strength and cyclic loading were validated against predicate devices (K131769 and K082215, respectively).

Technological Characteristics

Absorbable REGENESORB material; single-loaded #1 ULTRABRAID suture. Includes flexible/straight inserters, drills, and insertion accessories. Sterile, single-use. Biocompatible composition consistent with predicate devices.

Indications for Use

Indicated for soft tissue-to-bone reattachment in the hip (acetabular labrum repair/reconstruction) and shoulder (capsular stabilization, Bankart repair, anterior shoulder instability, SLAP lesion repairs, capsular shift/capsulolabral reconstructions, and biceps tenodesis).

Regulatory Classification

Identification

Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.

Predicate Devices

• OSTEORAPTOR OS Suture Anchor (K101459)
• OSTEORAPTOR Suture Anchor (K082215)
• NANOTACK Suture Anchor, 1.4mm (K131769)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

May 30, 2018

Smith and Nephew, Inc. Katherine Marcaccio Senior Regulatory Affairs Specialist 7135 Goodlett Farms Parkway Cordova, Tennessee 38016

## Re: K180361

Trade/Device Name: MICRORAPTOR REGENESORB Suture Anchor Regulation Number: 21 CFR 888.3030 Regulation Name: Single/multiple component metallic bone fixation appliances and accessories Regulatory Class: Class II Product Code: MAI Dated: April 26, 2018 Received: April 27, 2018

Dear Ms. Marcaccio:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{1}------------------------------------------------

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,

# Katherine D. Kavlock -S

for

Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

## Indications for Use

510(k) Number (if known) K180361

#### Device Name

MICRORAPTOR REGENESORB Suture Anchor

Indications for Use (Describe)

The Smith & Nephew MICRORAPTOR Suture Anchor is intended for the reattachment of soft tissue to the following indications:

Hip

Acetabular labrum repair/reconstruction

Shoulder

- Capsular stabilization
- Bankart repair
- Anterior shoulder instability
- SLAP lesion repairs
- Capsular shift or capsulolabral reconstructions
- Biceps tenodesis

| Type of Use (Select one or both, as applicable) | |
|-------------------------------------------------|--|
|-------------------------------------------------|--|

X Prescription Use (Part 21 CFR 801 Subpart D)

| Over-The-Counter Use (21 CFR 801 Subpart C)

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

T 978-749-1000 F 978-749-1443 www.smith-nephew.com

Image /page/3/Picture/2 description: The image shows the Smith & Nephew logo. The logo consists of an orange flower-like symbol on the left, followed by the text "We are smith&nephew". The words "We are" are in gray, while "smith&nephew" is in orange.

# 510(k) Summary

Prepared: 26 APRIL 2018

| Submitter Information | Contact Information |
|-----------------------|--------------------------------------|
| Smith & Nephew, Inc. | Katherine Marcaccio |
| Endoscopy Division | Senior Regulatory Affairs Specialist |
| 150 Minuteman Road | Phone: [phone] |
| Andover, MA 01810 | Fax: [phone] |

| Device Name & Classification | |
|------------------------------|------------------------------------------------|
| Proprietary Name | MICRORAPTOR REGENESORB Suture Anchor |
| Common Name | Soft Tissue Fixation Device |
| Classification Name | Fastener, fixation, biodegradable, soft tissue |
| Classification Regulation | 21 CFR 888.3030 |
| Class | II |
| Product Code(s) | MAI |
| Panel | Orthopedic |

#### Legally Marketed Predicate Devices

The Smith & Nephew MICRORAPTOR REGENESORB Suture Anchor is substantially equivalent in intended use and Fundamental Scientific Technology to the following legally marketed devices in commercial distribution:

| Description | Submission<br>Number | Clearance Date |
|-------------------------------|----------------------|------------------|
| OSTEORAPTOR OS Suture Anchor | K101459 | January 27, 2011 |
| OSTEORAPTOR Suture Anchor | K082215 | November 3, 2008 |
| NANOTACK Suture Anchor, 1.4mm | K131769 | October 7, 2013 |

#### Device Description

The Smith & Nephew MICRORAPTOR Suture Anchor consists of an anchor on a flexible and/or straight inserter, flexible and/or straight drill, and curved and/or straight insertion accessory instruments. The implant will be offered in an absorbable material (REGENESORB), single loaded #1 ULTRABRAID suture with multiple suture color offerings. This device is provided sterile, for single use only.

{4}------------------------------------------------

### Intended Use

The Smith & Nephew MICRORAPTOR Suture Anchor is intended for the reattachment of soft tissue to bone for the following indications:

Hip

- Acetabular labrum repair/reconstruction
### Shoulder

- · Capsular stabilization
- Bankart repair
- Anterior shoulder instability
- SLAP lesion repairs
- Capsular shift or capsulolabral reconstructions
- · Biceps tenodesis

#### Technological Characteristics

The Smith & Nephew MICRORAPTOR REGENESORB Suture Anchor is substantially equivalent in intended use and fundamental scientific technology to the legally marketed predicate devices - Smith and Nephew OSTEORAPTOR OS Suture Anchor (K101459), and the Pivot NANOTACK Suture Anchor, 1.4mm (K131769), and raises no new issues of safety and efficacy. The Smith & Nephew MICRORAPTOR REGENESORB Suture Anchor and the predicate OSTEORAPTOR OS Suture Anchor (K101459) use identical implant materials. The Smith & Nephew OSTEORAPTOR Suture Anchor (K082215) has identical geometry to the OSTEORAPTOR OS Suture Anchor (K101459), and is composed of absorbable PLLA/HA material. The Smith & Nephew MICRORAPTOR REGENESORB Suture Anchor and the predicate NANOTACK Suture Anchor, 1.4mm (K131769) have similar geometry.

#### Summary Performance Data

Bacterial endotoxin testing was completed and met acceptable endotoxin limits per ANSI/AAMI ST72:2011. Performance data demonstrates that the MICRORAPTOR REGENESORB Suture Anchor has met performance specifications for insertion strength based on the predicate Pivot NANOTACK Suture Anchor, 1.4mm (K131769). Performance data demonstrates that the MICRORAPTOR REGENESORB Suture Anchor has met performance specifications for cyclic loading based on the predicate OSTEORAPTOR Suture Anchor (K082215). Therefore, the MICRORAPTOR REGENESORB Suture Anchor is considered substantially equivalent to the currently marketed predicate devices.

#### Substantial Equivalence Information

The substantial equivalence of the MICRORAPTOR REGENESORB Suture Anchor is based on similarities in indications for use, design features, operational principles, material biocompatibility and composition, and performance to the predicate devices listed above. Based on the similarities to the predicates, the MICRORAPTOR REGENESORB Suture Anchor is substantially equivalent to its predicates.